Evidence map›Paper›PMID 35058582›Full record

ArticleBone marrow transplantation2022

The role of allogeneic haematopoietic cell transplantation as consolidation after anti-CD19 CAR-T cell therapy in adults with relapsed/refractory acute lymphoblastic leukaemia: a prospective cohort study.

Shi Han, Lijuan Zhou, Youyou Chen, Xuan Zhou, Zhenling Guo, Jilong Yang, Bo Jin, Yuchen Liu, Lung-Ji Chang, Yuhua Li and 1 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Shi Han *Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.ORCID http://orcid.org/0000-0003-4105-0437
Lijuan Zhou *Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Youyou ChenDepartment of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Xuan ZhouDepartment of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Zhenling GuoDepartment of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Jilong YangDepartment of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Bo JinDepartment of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Yuchen LiuDepartment of Research and Development, Geno-Immune Medical Institute, Shenzhen, China.
Lung-Ji ChangDepartment of Research and Development, Geno-Immune Medical Institute, Shenzhen, China.
Yuhua LiDepartment of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China. Liyuhua2011gz@163.com.ORCID http://orcid.org/0000-0001-7174-0338
Sanfang TuDepartment of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China. doctortutu@163.com.ORCID http://orcid.org/0000-0001-8834-6839
Zhujiang Hospital · CNShenzhen Genoimmune Medical Institute · CNGuangzhou Regenerative Medicine and Health Guangdong Laboratory · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematopoietic Stem Cell TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaReceptors, Chimeric AntigenAdultAntigens, CD19HumansImmunotherapy, AdoptiveProspective StudiesAntigens, CD19Receptors, Chimeric Antigen

Identifiers

PMID35058582
OpenAlexW4206403480

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.